Published by Piel con Maria · skinscan.guide

Why Your Dark Spots Keep Coming Back — And What Dermatologists in Latin America Do Differently

You’ve tried vitamin C serums. You’ve tried chemical peels. The spots faded... and came back darker than before.

You added a retinol. You layered an AHA toner. You wore sunscreen most days. Still — every time you think the spots are gone, they reappear. Sometimes in the same place. Sometimes worse.

The problem isn’t that you’re not trying. The problem is that you might be treating the wrong type of hyperpigmentation entirely.

Camila’s $200-a-Month Brightening Habit

Camila lives in Bogota. At 31, she noticed dark patches forming along her cheekbones after a beach trip to Cartagena. She did what most of us do — she went to the pharmacy and bought a brightening serum. Then another. Then a prescription hydroquinone cream from a friend’s recommendation.

Within a year, she was spending $200 a month on brightening products. The dark patches would lighten for a few weeks, then come back. Sometimes with a visible border where the cream had been applied — a telltale sign she was treating surface pigmentation while the real issue was deeper.

It wasn’t until she got a proper analysis — one that distinguished between post-inflammatory hyperpigmentation and melasma — that she understood why nothing was working. She had been treating melasma with products designed for PIH. Completely different mechanisms. Completely different protocols.

Once she knew what she was actually dealing with, her dermatologist put her on a targeted protocol. Within three months, the patches had visibly reduced. Within six months, her skin was more even than it had been in years.

The Three Types of Hyperpigmentation — And Why Treatment Differs

Not all dark spots are the same. Misidentification of hyperpigmentation type is one of the most common reasons treatments fail — particularly in patients with Fitzpatrick skin types III through V, which includes the majority of Latin American skin tones. A 2009 review by Cestari et al. in the Journal of the European Academy of Dermatology and Venereology found melasma prevalence of approximately 10% in Latin American populations, with rates reaching 50–80% among pregnant Latinas. A 2024 Brazilian survey found facial melasma in 36.3% of respondents — underscoring how common this condition is in the region.

1. Post-Inflammatory Hyperpigmentation (PIH)

PIH occurs after skin trauma — acne, a burn, an aggressive peel, even a mosquito bite. The skin produces excess melanin as part of its healing response, through a molecular mechanism involving inflammatory mediators that stimulate melanocyte activity (PMC9709857, 2022). According to Dr. Andrew Alexis, a leading skin-of-color dermatologist, PIH affects darker skin tones disproportionately because higher baseline melanin levels amplify the inflammatory pigment response. A 2024 systematic review by Kristie Mar et al. in the Journal of Cutaneous Medicine and Surgery — spanning 48 studies and 1,356 individuals — found that 70% of PIH study participants were Black, 27% Asian, and only 3% Latin, highlighting a significant research gap for this population. The review also found that topical retinoids achieved 85% partial improvement in PIH. The good news: PIH fades on its own over time, and responds well to vitamin C, niacinamide, retinoids, and consistent sunscreen use. The key is avoiding further inflammation while the skin heals.

2. Melasma

Melasma is hormonally driven — commonly triggered by pregnancy, birth control, or hormone replacement therapy. Cestari et al. (JEADV, 2009) found that 50–80% of pregnant Latinas develop some form of melasma. Unlike PIH, melasma sits deeper in the dermis and is notoriously difficult to treat. Aggressive peels and high-concentration hydroquinone can actually worsen it by triggering rebound hyperpigmentation — hydroquinone used at concentrations of 6–12% or continuously for more than 4–5 months carries a risk of ochronosis (PMC10723018, 2023). The gold-standard approach involves a triple combination cream — hydroquinone 4%, tretinoin 0.05%, and fluocinolone 0.01% — combined with rigorous broad-spectrum SPF 50+ and, increasingly, oral tranexamic acid at 250mg twice daily. Dr. Seemal Desai, a leading tranexamic acid optimization researcher (PubMed 37026889), has published extensively on refining TXA protocols for skin of color.

3. Sun Damage (Solar Lentigines)

These are the “age spots” that accumulate over decades of UV exposure. They’re concentrated on sun-exposed areas — face, hands, chest. Unlike PIH, they won’t fade on their own. And unlike melasma, they’re not hormonally driven. Treatment typically requires tyrosinase inhibitors (like kojic acid or arbutin), targeted retinoid therapy, or procedural interventions like IPL or fractional laser. The critical differentiator: sun damage is cumulative, not cyclical. Without rigorous SPF, new spots continue forming regardless of treatment.

Why Latin American Dermatology Approaches It Differently

Dermatologists practicing in Latin America deal with two compounding factors that most North American and European protocols don’t account for: higher melanin levels in the patient population and year-round intense UV exposure. The 2025 Latin American Consensus on melasma management — led by Dr. Jorge Ocampo-Candiani (UANL, Mexico) and published in the International Journal of Dermatology (Vol 64, Issue 3, pp. 499–512) — used DELPHI methodology with 9 experts from 9 countries to establish region-specific guidelines. The consensus emphasizes that aggressive treatments — high-concentration chemical peels, ablative lasers — carry significantly higher risk of post-inflammatory hyperpigmentation in darker skin. Latin American protocols tend to favor gentler, longer-duration approaches: lower-concentration tyrosinase inhibitors, careful retinoid titration, and mandatory high-SPF sun protection as a treatment step, not just prevention.

The Role of SPF — It’s Not Optional

The 2025 Latin American Consensus (Ocampo-Candiani et al., International Journal of Dermatology) is unequivocal: no hyperpigmentation treatment works without daily broad-spectrum sunscreen (SPF 50+, reapplied every 2 hours during sun exposure). SPF 15 blocks 93% of UVB, SPF 30 blocks 97%, and SPF 50 blocks 98% — but research consistently shows people apply only 25–50% of the required amount, significantly reducing real-world protection. UV radiation reactivates melanocytes in all three types of hyperpigmentation. This is why spots “come back” — the treatment reduces pigment, but unprotected sun exposure restarts the cycle. In tropical climates where UV index routinely exceeds 11, this is even more critical.

Identification Before Treatment

The difference between a treatment that works and one that wastes your money — or makes things worse — comes down to correctly identifying which type of hyperpigmentation you have. Skin Scan identifies which type of hyperpigmentation you have before you spend another dollar on the wrong treatment. The AI distinguishes between PIH, melasma, and sun damage patterns, then provides targeted guidance based on your specific condition.

Instead of guessing at the pharmacy or scrolling through contradictory advice online, you get clarity in seconds — along with recommendations that account for your skin tone, your climate, and the type of pigmentation you’re actually dealing with.